Hepcidin-25: Measurement by LC-MS/MS in serum and urine, reference ranges and urinary fractional excretion

Clinica Chimica Acta

Volumn 423, Issue , 2013, Pages 99-104

  Wolff, Fleur ^a   Deleers, Marie ^a   Melot, Christian ^a   Gulbis, Béatrice ^a   Cotton, Frédéric ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Chromatography; Hepcidin; Iron disorders; Mass spectrometry; Reference values; Renal behavior

Indexed keywords

FERRITIN; HEPCIDIN; HEPCIDIN 25; IRON; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IRON DEFICIENCY; IRON METABOLISM; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; VALIDATION STUDY;

ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; FEMALE; HEPCIDINS; HUMANS; IRON; MALE; MIDDLE AGED; REFERENCE VALUES; TANDEM MASS SPECTROMETRY; URINALYSIS; YOUNG ADULT;

EID: 84878208989     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.04.021     Document Type: Article

References (31)

1. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
2. Swinkels D.W., Girelli D., Laarakkers C., et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 2008, 3:e2706.
3. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
4. Nemeth E., Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006, 91:727-732.
5. Finberg K.E., Heeney M.M., Campagna D.R., et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008, 40:569-571.
6. Van der Putten K., Jie K.E., van den Broek D., et al. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. Eur J Heart Fail 2010, 12:943-950.
7. Nicolas G., Viatte L., Bennoun M., Beaumont C., Kahn A., Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 2002, 29:327-335.
8. Hunter H.N., Fulton D.B., Ganz T., Vogel H.J. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002, 277:37597-37603.
9. Kroot J.J., Tjalsma H., Fleming R.E., Swinkels D.W. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011, 57:1650-1669.
10. Castagna A., Campostrini N., Zaninotto F., Girelli D. Hepcidin assay in serum by SELDI-TOF-MS and other approaches. J Proteomics 2010, 73:527-536.
11. Bansal S.S., Halket J.M., Fusova J., et al. Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009, 23:1531-1542.
12. Murao N., Ishigai M., Yasuno H., Shimonaka Y., Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom 2007, 21:4033-4038.
13. Murphy A.T., Witcher D.R., Luan P., Wroblewski V.J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007, 110:1048-1054.
14. Kobold U., Dülffer T., Dangl M., et al. Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry. Clin Chem 2008, 54:1584-1586.
15. Bansal S.S., Halket J.M., Bomford A., et al. Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometry. Anal Biochem 2009, 384:245-253.
16. Bansal S.S., Abbate V., Bomford A., et al. Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom 2010, 24:1251-1259.
17. Hwang S.I., Lee Y.Y., Park J.O., et al. Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC-MS/MS method. Clin Chim Acta 2011, 412:2241-2247.
18. Li H., Rose M.J., Tran L., et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009, 59:171-180.
19. Houbart V., Cobraiville G., Lecomte F., Debrus B., Hubert P., Fillet M. Development of a nano-liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation. J Chromatogr A 2011, 1218:9046-9054.
20. Itkonen O., Parkkinen J., Stenman U.H., Hämäläinen E. Preanalytical factors and reference intervals for serum hepcidin LC-MS/MS method. Clin Chim Acta 2012, 413:696-701.
21. Kroot J.J., Kemna E.H., Bansal S.S., et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009, 94:1748-1782.
22. Hubert P., Nguyen-Huu J.J., Boulanger B., et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal-part I. J Pharm Biomed Anal 2004, 36:579-586.
23. Hubert P., Nguyen-Huu J.J., Boulanger B., et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal-part II. J Pharm Biomed Anal 2007, 45:70-81.
24. Hubert P., Nguyen-Huu J.J., Boulanger B., et al. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal-part III. J Pharm Biomed Anal 2007, 45:82-96.
25. Hubert P., Nguyen-Huu J.J., Boulanger B., et al. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. J Pharm Biomed Anal 2008, 48:760-771.
26. Viswanathan C.T., Bansal S., Booth B., et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res 2007, 24:1962-1973.
27. Levey A.S., Stevens L.A., Schmid C.H., et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
28. Mast A.E., Blinder M.A., Gronowski A.M., Chumley C., Scott M.G. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998, 44:45-51.
29. Kroot J.J., Van Herwaarden A.E., Tjalsma H., Jansen R.T., Hendriks J.C., Swinkels D.W. Second round robin for plasma hepcidin methods: first steps towards harmonization. Am J Hematol 2012, 87:977-983.
30. Kroot J.J., Hendriks J.C., Laarakkers C.M., et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem 2009, 389:124-129.
31. Galesloot T.E., Vermeulen S.H., Geurts-Moespot A.J., et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011, 117:218-225.